Certara [CERT] vs Teladoc Health [TDOC] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Certara Inc. wins in 9 metrics, Teladoc Health Inc. wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Certara Inc. Teladoc Health Inc. Better
P/E Ratio (TTM) 105.00 N/A N/A
Price-to-Book Ratio 0.95 0.74 Teladoc Health Inc.
Debt-to-Equity Ratio 28.96 75.06 Certara Inc.
PEG Ratio -0.53 -6.16 Certara Inc.
EV/EBITDA 11.42 38.86 Certara Inc.
Profit Margin (TTM) -0.38% -7.92% Certara Inc.
Operating Margin (TTM) 2.08% -4.20% Certara Inc.
EBITDA Margin (TTM) 2.08% N/A N/A
Return on Equity -0.15% -13.93% Certara Inc.
Return on Assets (TTM) 0.93% -3.20% Certara Inc.
Free Cash Flow (TTM) $69.77M $137.33M Teladoc Health Inc.
1-Year Return -52.77% 7.00% Teladoc Health Inc.
Price-to-Sales Ratio (TTM) 2.31 0.41 Teladoc Health Inc.
Enterprise Value $1.12B $1.28B Teladoc Health Inc.
EV/Revenue Ratio 2.68 0.51 Teladoc Health Inc.
Gross Profit Margin (TTM) 62.21% 69.32% Teladoc Health Inc.
Revenue per Share (TTM) $3 $14 Teladoc Health Inc.
Earnings per Share (Diluted) $-0.01 $-34.20 Certara Inc.
Beta (Stock Volatility) 1.62 2.08 Certara Inc.
Short % of Float 22.71% 16.55% Teladoc Health Inc.

Certara Inc. vs Teladoc Health Inc. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Certara Inc.0.19%-0.19%16.29%-19.72%-40.39%-40.39%
Teladoc Health Inc.1.63%5.37%17.30%38.40%1.63%5.82%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Certara Inc.-52.77%-70.03%-81.17%-86.34%-86.34%-86.34%
Teladoc Health Inc.7.00%-70.52%-95.30%-42.92%-73.79%-73.79%

Performance & Financial Health Analysis: Certara Inc. vs Teladoc Health Inc.

MetricCERTTDOC
Market Information
Market Cap i$969.01M$1.04B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i2,754,2634,716,750
90 Day Avg. Volume i4,134,9514,439,277
Last Close$5.21$7.46
52 Week Range$4.45 - $13.88$4.40 - $9.77
% from 52W High-62.46%-23.64%
All-Time High$45.48 (Nov 01, 2021)$308.00 (Feb 15, 2021)
% from All-Time High-88.54%-97.58%
Growth Metrics
Quarterly Revenue Growth0.03%0.00%
Quarterly Earnings Growth0.03%0.00%
Financial Health
Profit Margin (TTM) i0.00%-0.08%
Operating Margin (TTM) i0.02%-0.04%
Return on Equity (TTM) i0.00%-0.14%
Debt to Equity (MRQ) i28.9675.06
Cash & Liquidity
Book Value per Share (MRQ)$6.68$7.77
Cash per Share (MRQ)$1.19$4.38
Operating Cash Flow (TTM) i$96.33M$294.36M
Levered Free Cash Flow (TTM) i$96.40M$226.14M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Certara Inc. vs Teladoc Health Inc.

MetricCERT (Apr 26, 2026)TDOC (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i105.00N/A
Forward P/E i12.87-6.16
PEG Ratio i-0.53-6.16
Price to Sales (TTM) i2.310.41
Price to Book (MRQ) i0.950.74
Market Capitalization
Market Capitalization i$969.01M$1.04B
Enterprise Value i$1.12B$1.28B
Enterprise Value Metrics
Enterprise to Revenue i2.680.51
Enterprise to EBITDA i11.4238.86
Risk & Other Metrics
Beta i1.622.08
Book Value per Share (MRQ) i$6.68$7.77

Financial Statements Comparison: Certara Inc. vs Teladoc Health Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCERT (2025)TDOC (2025)
Revenue/Sales i418.84M2.53B
Cost of Goods Sold i161.13M771.59M
COGS % of Revenue i38.5%30.5%
Gross Profit i257.71M1.76B
Gross Margin i61.5%69.5%
Research & Development i41.04M277.92M
Operating Income (EBIT) i21.02M-163.40M
Operating Margin i5.0%-6.5%
EBITDA i102.52M260.18M
EBITDA Margin i24.5%10.3%
Pre-Tax Income i7.62M-235.53M
Pre-Tax Income % of Revenue i1.8%-9.3%
Income Tax i9.21M-35.21M
Income Tax % of Revenue i2.2%-1.4%
Net Income (Profit) i-1.60M-200.32M
Profit Margin i-0.4%-7.9%

Balance Sheet & Liquidity Metrics

MetricCERT (2025)TDOC (2025)
Cash & Equivalents i189.39M781.08M
Total Current Assets i315.12M1.12B
Total Current Assets % of Revenue i75.2%44.2%
Total Current Liabilities i153.39M404.74M
Total Current Liabilities % of Revenue i36.6%16.0%
Long-Term Debt i298.57M1.03B
Long-Term Debt % of Revenue i71.3%40.7%
Total Shareholders Equity i1.06B1.39B
Retained Earnings i-129.88M-16.43B
Retained Earnings % of Revenue i-31.0%-649.4%
Property, Plant & Equipment i11.94M42.03M

Cash Flow Statement Comparison

MetricCERT (2025)TDOC (2025)
Operating Cash Flow i91.68M225.59M
Operating Cash Flow % of Revenue i21.9%8.9%
Capital Expenditures iN/AN/A
Free Cash Flow i69.77M137.33M
FCF Margin i16.7%5.4%
Debt Repayment i-2.99M-550.63M
Common Stock Repurchase i-42.61MN/A

Short Interest & Institutional Ownership Analysis

MetricCERTTDOC
Shares Short i22.29M29.71M
Short Ratio i5.096.89
Short % of Float i22.71%16.55%
Shares Outstanding i159.14M178.32M
Float Shares i109.20M176.23M
% Held by Insiders i2.50%0.65%
% Held by Institutions i116.00%75.86%
% Held by Public i-18.50%23.49%

Dividend Analysis & Yield Comparison: Certara Inc. vs Teladoc Health Inc.

MetricCERTTDOC
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A